Variable

Frequency

<1000 cp/ml

>1000 cp/ml

X2

Ages

19 - 25 yrs

743 (7.9)

532 (71.6)

211 (28.4)

<0.001

26 - 45 yrs

6572 (69.5)

5028 (76.5)

1544 (23.5)

46 - 55 yrs

1473 (15.6)

1179 (80.0)

294 (20.0)

56 - 65 yrs

523 (5.5)

430 (82.2)

93 (17.8)

>65 yrs

139 (1.5)

114 (82.0)

25 (18.0)

Sex

Males

2577 (27.3)

1990 (77.2)

587 (22.8)

0.829

Females

6873 (72.7)

5293 (77.0)

1580 (23.0)

ART Regimen

AZT + 3TC + NVP

4962 (52.5)

3751 (75.6)

1211 (24.4)

<0.001

TDF + 3TC + EFV

4375 (46.3)

3449 (78.8)

926 (21.2)

TDF + FTC + EFV

113 (1.2)

83 (73.5)

30 (26.5)

ART Type

1st line

9184 (97.2)

7103 (77.4)

2081 (22.6)

<0.001

2nd line

239 (2.5)

164 (68.6)

75 (31.4)

3rd line

27 (0.3)

16 (59.3)

11 (40.7)

Duration on ART

1 yr

699 (7.4)

517 (74.0)

182 (26.0)

<0.001

1 - 5 yrs

4568 (48.3)

3593 (78.7)

975 (21.3)

6 - 10 yrs

3551 (37.6)

2666 (75.1)

885 (24.9)

> 10 yrs

632 (6.7)

507 (80.2)

125 (19.8)

CD4 count

<350

2992 (31.7)

1963 (65.6)

1029 (34.4)

<0.001

350 - 499

2195 (23.2)

1756 (80.0)

439 (20.0)

500 - 999

3651 (38.6)

3051 (83.6)

600 (16.4)

>1000

612 (6.5)

513 (83.8)

99 (16.2)

Reason for request of viral load

Routine

9098 (96.3)

7012 (77.9)

2086 (22.1)

<0.001

Suspected clinical failure

232 (2.5)

195 (84.1)

37 (15.9)

Suspected immunological failure

120 (1.3)

76 (63.3)

44 (36.7)

ART Start Year

2000-2004

29 (0.3)

27 (93.1)

2 (6.9)

0.052

2005-2009

2214 (23.4)

1674 (75.6)

540 (24.4)

2010-2014

4892 (51.8)

3797 (77.6)

1095 (22.4)

2015-2018

2315 (24.5)

1785 (77.1)

530 (22.9)